|
|
Article: Agilent Technologies Acquires Computational Biology Corp., Pioneer in Gene Regulation Analysis.
- Article from:
- Business Wire
- Article date:
- January 5, 2005
CopyrightCOPYRIGHT 2005 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
PALO ALTO, Calif. -- Agilent Gains Exclusive Access to Intellectual Property for ChIP-on-Chip, Plans Collaborative Research Center in Cambridge, Mass.
Agilent Technologies Inc. (NYSE:A) today announced its acquisition of Computational Biology Corp., a biotech pioneer in ChIP-on-chip, a microarray-based technique for understanding gene regulation in disease. The acquisition gives Agilent exclusive access to the critical patent and intellectual property for ChIP-on-chip analysis that will enable the company to provide unique microarray solutions for disease research, drug discovery and drug development.
Computational Biology Corp., based in Cambridge, ...